Perimenopause
Stage Finder
10 questions. 3 minutes. Find out exactly where you are in your perimenopause journey — and get a personalised action plan for your specific stage.
What Is Perimenopause?
Perimenopause is the hormonal transition period that precedes menopause — typically lasting 4–10 years and beginning on average at age 38–45, though it can start as early as 35. It is not a single event but a gradual process during which oestrogen and progesterone levels fluctuate erratically before declining to their post-menopausal baseline.
How This Quiz Identifies Your Stage
The quiz assesses 10 distinct clinical domains that collectively define perimenopause stage — weighting them according to their diagnostic strength in published perimenopause staging research, including the STRAW+10 (Stages of Reproductive Ageing Workshop) criteria.
| Domain | Max Points | Why It’s Included |
|---|---|---|
| Menstrual Changes | 6 | Primary STRAW+10 criterion — cycle irregularity is the most reliable stage marker |
| Hot Flashes & Night Sweats | 6 | Vasomotor symptoms correlate strongly with oestrogen withdrawal severity |
| Sleep Quality | 6 | Sleep disruption is both a symptom of and driver of perimenopausal symptom burden |
| Weight & Metabolism | 6 | Visceral fat redistribution is a key marker of oestrogen decline timeline |
| Mood & Cognition | 6 | Brain symptoms correlate with hormone fluctuation amplitude, not just level |
| Energy Levels | 6 | Mitochondrial function declines with oestrogen withdrawal; energy is a reliable proxy |
| Libido & Vaginal Health | 6 | Genitourinary syndrome of menopause (GSM) progresses predictably through stages |
| Skin & Hair | 6 | Collagen and hair follicle changes reflect cumulative oestrogen exposure decline |
| Age | 6 | Age is an independent predictor of stage — perimenopause is age-stratified |
| Family History | 5 | Timing of menopause has 60%+ heritability; maternal age is a strong predictor |
The Four Stages of Perimenopause
Perimenopause is not a single phase but a progressive sequence of four clinically distinct stages, each with its own hormonal signature, symptom pattern, and optimal management approach. Identifying your stage is the foundation of effective intervention.
| Stage | Typical Age | Hormonal Pattern | Key Characteristics | Years to Menopause |
|---|---|---|---|---|
| 🟢 Pre-Peri | 35–42 | Progesterone declining; oestrogen mostly stable but with early fluctuations | Regular or slightly irregular cycles; subtle PMS worsening; early sleep changes; often attributed to stress | 8–15+ years |
| 🟡 Early Peri | 40–47 | Oestrogen becoming erratic; FSH rising; anovulatory cycles increasing | Noticeable cycle changes; hot flashes beginning; sleep disruption; mood changes; weight redistribution starting | 4–10 years |
| 🟠 Mid Peri | 45–51 | Oestrogen in significant flux — high amplitude swings; progesterone very low | Significant symptoms affecting daily life; brain fog; visceral weight gain; sleep severely disrupted; hot flashes frequent | 2–6 years |
| 🟣 Late Peri | 48–52 | Oestrogen consistently low; FSH persistently elevated; cycles rare | Near or final periods; vaginal changes; bone loss accelerating; cardiovascular risk rising; symptoms may plateau or peak | 1–3 years |
Menstrual Changes — The Primary Stage Marker
Cycle changes are the most diagnostically reliable markers of perimenopause stage, forming the primary axis of the STRAW+10 staging system. Understanding what your cycle changes mean gives you the clearest window into where you are in the transition.
🟢 Early Signs (Pre-Perimenopause)
Cycles remain largely regular but may shorten by 2–4 days. PMS symptoms may worsen as progesterone declines relative to oestrogen. Cycle length variability increases slightly. Many women notice nothing unusual at this stage — the changes are subtle and easy to attribute to stress.
🟡 Early Perimenopause Signal
The STRAW+10 criterion for early perimenopause: cycles that vary by 7 or more days from the typical cycle length on at least two occasions. This reflects the first anovulatory cycles — when the ovaries don’t release an egg and progesterone doesn’t rise in the luteal phase.
🟠 Mid-to-Late Perimenopause
Cycles become unpredictable — some very close together, some months apart. Flow changes: heavier flooding periods alternate with lighter cycles. Long gaps of 60+ days between periods signal late perimenopause. This erratic pattern reflects oestrogen’s highest fluctuation amplitude of the entire transition.
🔵 Menopause Definition
Menopause is defined as 12 consecutive months without a menstrual period. It is a retrospective diagnosis — you only know you have reached menopause after 12 period-free months. The average US age is 51.4 years; before age 45 is considered early menopause; before 40 is premature ovarian insufficiency (POI).
Hot Flashes, Night Sweats & Vasomotor Symptoms
Vasomotor symptoms (VMS) — hot flashes and night sweats — affect 75–80% of women during perimenopause and are the hallmark symptom of the transition. Understanding their mechanism helps explain both why they occur and what interventions are most effective.
🌡️ The Mechanism
As oestrogen declines, the hypothalamus’s thermoneutral zone — the temperature range within which neither sweating nor shivering is triggered — narrows dramatically. Even small rises in core body temperature that would normally be ignored now trigger full heat-dissipation responses: peripheral vasodilation (flushing), sweating, and heart rate increase. This is a normal physiological response to a disrupted thermostat, not a psychological event.
📊 Severity Patterns by Stage
VMS typically worsen through early and mid-perimenopause, peaking in the 2 years before and after the final period — then gradually improving over 3–7 years post-menopause. Approximately 25% of women have VMS for 10+ years. Severity is predicted by BMI (higher BMI → more severe), smoking, stress levels, and sleep quality — all modifiable factors.
🌙 Night Sweats Specifically
Night sweats — nocturnal hot flashes — are particularly disruptive because they fragment sleep architecture, reducing slow-wave sleep and increasing cortisol. This creates a feedback loop: poor sleep raises cortisol, elevated cortisol increases hot flash frequency, more hot flashes further disrupt sleep. Breaking this cycle is the primary objective of early intervention.
🎯 Most Effective Interventions
Evidence hierarchy for VMS: HRT (75–90% reduction — most effective); SSRI/SNRI antidepressants (40–60% off-label); fezolinetant (FDA-approved 2023, non-hormonal); CBT and mindfulness (30–40%); regular exercise (25–30%); isoflavones (20–30% with consistent use); paced breathing during episodes (acute relief); avoiding triggers (alcohol, spicy food, hot drinks).
Brain Fog, Mood & the Cognitive Perimenopause
Cognitive and mood symptoms are among the most common and least medically recognised aspects of perimenopause. Women frequently report difficulty concentrating, word-finding problems, memory lapses, anxiety, and mood instability during perimenopause — and these are biologically real, not psychological.
| Symptom | Biological Mechanism | Stage It Peaks | Best Interventions |
|---|---|---|---|
| Brain Fog / Memory Lapses | Oestrogen supports glucose metabolism in the hippocampus; its decline reduces neuronal energy supply and memory consolidation | Mid perimenopause | Exercise (BDNF); omega-3 DHA; sleep; adequate protein; HRT in window of opportunity |
| Anxiety (new or worsening) | Oestrogen modulates GABA (calming) and serotonin pathways; fluctuating levels produce neurological instability and heightened threat response | Early-to-mid perimenopause | Magnesium; CBT; regular exercise; yoga; ashwagandha; progesterone (if low) |
| Depression / Low Mood | Oestrogen-serotonin interaction; sleep disruption; inflammatory changes; HPA axis dysregulation during hormonal flux | Transition years (2yr pre/post FMP) | Medical evaluation; SSRI if needed; HRT; exercise; light therapy; CBT |
| Irritability / Emotional Reactivity | Progesterone’s GABA-modulating effect is lost as progesterone declines; oestrogen spikes can temporarily amplify emotional responses | Early perimenopause (progesterone drops first) | Progesterone support; stress reduction; mindfulness; evaluate thyroid |
Weight, Metabolism & Body Composition Changes
The perimenopausal body composition shift — characterised by visceral fat gain in the abdomen, accelerating muscle loss, and metabolic rate decline — is one of the most distressing aspects of the transition. Understanding why it happens makes the interventions clearer.
📊 The Fat Redistribution Mechanism
Oestrogen directs fat to the hips, thighs, and buttocks (the gluteal-femoral depot) — which is metabolically protective. As oestrogen declines, this directional signal is lost and fat preferentially redistributes to the visceral (abdominal) depot. Women gain approximately 1.5 kg of visceral fat during the menopause transition independently of total calorie intake.
💪 Accelerating Muscle Loss
Sarcopenia (muscle loss) accelerates significantly post-45 in women — driven by oestrogen’s anabolic role in muscle protein synthesis and its anti-inflammatory effects in muscle tissue. Women who do not perform resistance training can lose 1–3% of lean mass per year during perimenopause. This muscle loss directly reduces metabolic rate (BMR).
✅ What Actually Works
The combination with the strongest evidence for perimenopausal body composition management: resistance training 3–4×/week (preserves lean mass; reduces visceral fat; improves insulin sensitivity) + protein 1.6–2.2g/kg/day (prevents muscle catabolism) + HRT if appropriate (directly reduces visceral fat accumulation). Caloric restriction alone without these components accelerates muscle loss.
✅ The Scale Is Misleading
Women in perimenopause who begin resistance training often experience the “body recomposition paradox”: scale weight stays the same or increases slightly while waist circumference decreases and body fat percentage falls. This occurs because muscle (denser than fat) replaces fat. Waist measurement monthly is a far more meaningful progress indicator than scale weight.
HRT — What the Current Evidence Says for Each Stage
Hormone Replacement Therapy has different evidence profiles, risk-benefit calculations, and practical considerations depending on which perimenopause stage you are in. Stage-specific guidance helps you have an informed conversation with your doctor.
| Stage | HRT Consideration | Primary Benefit | Evidence Level |
|---|---|---|---|
| Pre-Perimenopause | Generally not indicated; lifestyle interventions are first-line | Prophylactic HRT not evidence-supported at this stage | N/A — lifestyle focus |
| Early Perimenopause | Progesterone support first (addresses the initial progesterone deficit); low-dose oestrogen if VMS are present | Sleep improvement; mood stability; VMS prevention | Strong — early intervention yields most benefit |
| Mid Perimenopause | Full HRT (oestrogen + progestogen) most appropriate; within 10-year window of opportunity for cardiovascular protection | VMS; sleep; mood; bone; metabolism; cognitive protection | Very Strong — broadest benefit profile |
| Late Perimenopause | HRT most urgent for bone protection; local oestrogen for GSM independent of systemic HRT decision | Bone density; cardiovascular risk; GSM; quality of life | Strong — bone and cardiovascular benefits strongest here |
Non-HRT Management by Symptom
For women who prefer not to use HRT, or who want to complement it with lifestyle strategies, these evidence-based non-pharmaceutical interventions address the most common perimenopausal symptoms with meaningful clinical effect sizes.
🌡️ Hot Flashes
Best evidence: phytoestrogens (40–80mg isoflavones/day, 20–30% reduction); MBSR/mindfulness (35–40% reduction in perceived severity); regular exercise (25%); paced breathing (acute); fezolinetant (FDA-approved 2023, non-hormonal). Avoid: alcohol, spicy food, hot beverages, smoking.
😴 Sleep
CBT-I is the most effective long-term insomnia treatment — outperforms sleep medication at 6 months. Magnesium glycinate 300mg before bed; consistent wake time regardless of sleep quality; bedroom 17–19°C; no alcohol (worsens night sweats). Melatonin 0.5mg for sleep onset only.
🧠 Brain Fog
Regular aerobic exercise (most evidence — raises BDNF); omega-3 DHA 2g/day; consistent sleep; ashwagandha (cortisol reduction supports cognition); social engagement; continued learning. Brain fog typically improves significantly 1–2 years after the final period as oestrogen stabilises at its new baseline.
😰 Anxiety & Mood
Resistance training and yoga are as effective as antidepressants for perimenopausal anxiety in multiple RCTs. Magnesium 400mg; saffron extract 30mg/day has RCT evidence; CBT addresses catastrophising about symptoms; progesterone support for low-progesterone anxiety (pre-perimenopause pattern).
⚖️ Weight
Resistance training 3–4×/week is the primary intervention — not calorie restriction (which accelerates muscle loss). Protein 1.6–2.2g/kg/day. Mediterranean diet reduces visceral fat independently of calories. Strength training + protein together reduce perimenopausal visceral fat accumulation by 40–50% in 12-week studies.
🦴 Bone Health
Resistance + impact exercise (most effective non-pharmaceutical bone intervention); calcium 1,200mg/day from food or supplements; vitamin D3 2,000–4,000 IU/day (most women are deficient); adequate protein (bone is 35% collagen — protein-dependent). Request DEXA scan from age 50 or earlier with risk factors.
Medical Testing — What to Ask For at Each Stage
Standard GP blood panels rarely include the tests most useful for perimenopause staging and management. Knowing exactly what to request — and interpreting what results mean — helps you advocate for appropriate care.
| Test | Why It Matters for Perimenopause | Optimal Timing | Optimal Range |
|---|---|---|---|
| FSH (Follicle-Stimulating Hormone) | Rising FSH is the most reliable hormonal marker of perimenopause progression; above 10 IU/L suggests early transition | Day 2–5 of cycle | Pre-peri: 3–10 IU/L; rising FSH confirms transition |
| Oestradiol (E2) | Fluctuates widely in perimenopause — single test has limited value; trend over time is more informative | Day 2–5 of cycle | Follicular: 30–300 pg/mL; declining trend suggests progression |
| Progesterone | Progesterone is first to decline; low day-21 progesterone confirms anovulatory cycles and identifies the primary deficiency | Day 21 of cycle (luteal phase) | Should be above 15 nmol/L post-ovulation; low suggests anovulation |
| TSH + Free T3 + Free T4 | Thyroid dysfunction mimics perimenopause exactly — fatigue, weight gain, mood changes, hair loss. Must be ruled out | Any time; morning preferred | TSH 1.0–2.5 mIU/L optimal; Free T3 should be mid-upper range |
| Vitamin D (25-OH) | Deficiency worsens bone loss, mood, fatigue, and immune function — widespread and easy to correct | Any time | Optimal: 50–80 ng/mL; most perimenopausal women are below 30 |
| Fasting Insulin + Glucose | Insulin resistance increases significantly in perimenopause — directly drives visceral fat accumulation | Fasted (12 hours) | Fasting insulin below 8 µU/mL; HOMA-IR below 2.0 |
| DEXA Scan (Bone Density) | Bone loss accelerates 3–5%/year in early menopause — DEXA provides baseline and tracks intervention effectiveness | Age 50, or 45 with risk factors | T-score above −1.0 is normal; below −2.5 is osteoporosis |
Finding Specialist Menopause Care in the US
Only 7% of US doctors have received formal training in menopause care — a figure that reflects a systemic gap in women’s healthcare. Knowing how to find a qualified specialist significantly improves the quality of care available to you.
🔍 NAMS Menopause Practitioner Directory
The North American Menopause Society (NAMS) maintains a directory of certified menopause practitioners at menopause.org. NAMS-certified practitioners have passed rigorous examinations in menopause medicine and are the most qualified clinicians in this field. Search by ZIP code for practitioners near you.
👩⚕️ What to Ask Your GP First
Before seeking a specialist: ask your GP “Are you familiar with the current NAMS guidelines on perimenopause management?” This single question reliably identifies whether your GP is up to date. If the answer is hesitant, requesting a referral to a gynaecologist or endocrinologist with menopause expertise is appropriate.
💻 Telehealth Menopause Services
Several US telehealth platforms now specialise in menopause care: Midi Health, Evernow, Gennev, and Alloy are among those staffed by menopause-trained practitioners. Telehealth options can be particularly valuable for women in areas with limited local specialist access and for initial hormonal evaluation and prescription.
📋 Preparing for Your Appointment
For the most effective first appointment: bring a 3-month symptom diary noting cycle dates, hot flash frequency, sleep quality, and mood. Have your answers from this quiz printed or noted. Specifically request FSH, oestradiol, progesterone (day 21), thyroid panel, vitamin D, and fasting insulin if not recently tested. Being specific dramatically improves appointment efficiency.
Your Perimenopause Stage Action Plan
Regardless of your quiz result, these foundational actions apply to every stage of perimenopause — with the specific emphasis shifting based on where you are in the transition.
🏋️ Non-Negotiable: Resistance Training
The single most important lifestyle intervention at every perimenopause stage — for bone density, muscle preservation, visceral fat reduction, insulin sensitivity, mood, and cognitive protection. 3–4 sessions per week with progressive overload is the evidence-based minimum. Start immediately regardless of current fitness level.
🥩 Non-Negotiable: Protein Intake
Increase daily protein to 1.6–2.2g/kg of body weight. For a 65kg woman, this is 104–143g daily. This target is significantly higher than general dietary guidelines and is specifically required to prevent the accelerated muscle loss of perimenopause. Distribute across 3–4 meals, 30–40g each.
🩺 Non-Negotiable: Seek Specialist Care
The 7% of trained doctors figure means you need to be proactive. Book an appointment with a NAMS-certified practitioner or gynaecologist with menopause expertise. Bring your symptom history. Request the blood panel from Section 10. This conversation should happen at every stage — the earlier the better.
📊 Non-Negotiable: Track Waist Monthly
Measure your waist circumference monthly at the belly button, same time, same conditions. This is more meaningful than scale weight for monitoring perimenopausal metabolic change. A waist above 35 inches (88cm) indicates elevated metabolic and cardiovascular risk that warrants immediate attention.
| Your Quiz Stage | Immediate Priority | Medical Action | 6-Month Goal |
|---|---|---|---|
| 🟢 Pre-Perimenopause | Start resistance training; optimise protein and vitamin D | Baseline blood panel (TSH, vitamin D, fasting glucose, ferritin) | Build peak bone density and lean mass before oestrogen declines |
| 🟡 Early Perimenopause | Resistance training 3×/week; address sleep quality | FSH + oestradiol + progesterone (day 21) + thyroid + fasting insulin | Maintain muscle mass; establish sleep routine; hormonal baseline |
| 🟠 Mid Perimenopause | Medical evaluation for HRT; increase protein to 2g/kg | Full hormonal panel; fasting insulin; vitamin D; DEXA if not done | Symptom management plan; HRT decision made; waist measurement stabilised |
| 🟣 Late Perimenopause | Find menopause specialist; DEXA scan; HRT discussion | DEXA + full lipid panel + blood pressure + full hormonal panel | Bone protection strategy established; cardiovascular risk assessed; quality of life maintained |
Please consult a qualified healthcare provider or NAMS-certified menopause specialist for clinical evaluation and personalised care.